← back to search

Achim Gass

Heidelberg University · DE
Area of research
Pathology and Forensic Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Multiple Sclerosis Research Studies, Advanced Neuroimaging Techniques and Applications, Advanced MRI Techniques and Applications, and Acute Ischemic Stroke Management.
h-index
65
citations
15,962
works
382
NIH funding
primary concept
email

Recent publications

Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology 2024cited by 9position: middledoi
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology 2023cited by 219position: middledoi
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis
Acta Neuropathologica 2023cited by 35position: middledoi
Cerebrospinal fluid–related tissue damage in multiple sclerosis patients with iron rim lesions
Multiple Sclerosis Journal 2023cited by 13position: middledoi
Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions
Multiple Sclerosis Journal 2022cited by 13position: lastdoi
Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesions
Magnetic Resonance Imaging 2022cited by 11position: middledoi
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Therapeutic Advances in Neurological Disorders 2021cited by 184position: middledoi
The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective
Brain 2021cited by 56position: middledoi
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
Der Nervenarzt 2021cited by 24position: middledoi
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy
Brain 2021cited by 19position: middledoi
Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
Neurological Research and Practice 2021cited by 14position: middledoi
Intrathecal activation of CD8+ memory T cells in IgG4‐related disease of the brain parenchyma
EMBO Molecular Medicine 2021cited by 12position: middledoi
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Brain 2019cited by 545position: middledoi
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Neurology 2019cited by 47position: middledoi
Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral
Annals of Neurology 2019cited by 39position: middledoi
What remains after transient global amnesia (TGA)? An ultra‐high field 7 T magnetic resonance imaging study of the hippocampus
European Journal of Neurology 2019cited by 25position: middledoi
Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis
Magnetic Resonance Imaging 2019cited by 18position: lastdoi
Apheresis therapies for NMOSD attacks
Neurology Neuroimmunology & Neuroinflammation 2018cited by 231position: middledoi
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
Alzheimer s Research & Therapy 2016cited by 297position: middledoi
A common brain network links development, aging, and vulnerability to disease
Proceedings of the National Academy of Sciences 2014cited by 340position: middledoi
Global N-Acetylaspartate in Normal Subjects, Mild Cognitive Impairment and Alzheimer's Disease Patients
Journal of Alzheimer s Disease 2014cited by 32position: middledoi
Impaired Anatomical Connectivity and Related Executive Functions: Differentiating Vulnerability and Disease Marker in Bipolar Disorder
Biological Psychiatry 2013cited by 100position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Platten · German Cancer Research Center7 papers (2019–2023)Philipp Eisele · University Hospital Heidelberg6 papers (2019–2023)Lucas Schirmer · University of Mannheim4 papers (2022–2023)Claudia E. Weber · University Hospital Heidelberg4 papers (2022–2023)Matthias Wittayer · Johannes Gutenberg University Mainz3 papers (2022–2023)Daniel S. Reich · National Institutes of Health2 papers (2019–2021)Mike P. Wattjes · Humboldt-Universität zu Berlin2 papers (2019–2021)Frederik Barkhof · The Queen's Medical Research Institute2 papers (2019–2019)Kristina Szabo · University Hospital Heidelberg2 papers (2019–2019)Olga Ciccarelli · Queen Mary University of London2 papers (2019–2019)Imke Metz · Medizinische Hochschule Hannover2 papers (2021–2021)Maria A. Rocca · Vita-Salute San Raffaele University2 papers (2019–2019)Massimo Filippi · McGill University Health Centre2 papers (2019–2019)Andreas U. Monsch · Felix Platter-Hospital2 papers (2014–2014)Irene Cortese · Medizinische Hochschule Hannover1 papers (2021–2021) · 1 papers (2016–2016)Tania Kümpfel · Imperial College London1 papers (2021–2021)Hayrettin Tumani · University Hospital Ulm1 papers (2023–2023)Henry Rusinek · New York University1 papers (2014–2014)Nicola De Stefano · University of Siena1 papers (2019–2019)